Company registration number 06881034 (England and Wales)
ANAESTHETIC RESOURCE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
PAGES FOR FILING WITH REGISTRAR
ANAESTHETIC RESOURCE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ANAESTHETIC RESOURCE LIMITED
BALANCE SHEET
AS AT 30 APRIL 2025
30 April 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
2,350
3,525
Current assets
Debtors
6
14,594
14,769
Cash at bank and in hand
7,165
10,787
21,759
25,556
Creditors: amounts falling due within one year
7
(8,678)
(5,110)
Net current assets
13,081
20,446
Net assets
15,431
23,971
Capital and reserves
Called up share capital
104
104
Profit and loss reserves
15,327
23,867
Total equity
15,431
23,971

The notes on pages 2 to 5 form part of these financial statements.

For the financial year ended 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 15 May 2025 and are signed on its behalf by:
Dr H Ruschen
Director
Company registration number 06881034 (England and Wales)
ANAESTHETIC RESOURCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025
- 2 -
1
Accounting policies
Company information

Anaesthetic Resource Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Highfield Mead, East Hanningfield, Chelmsford, United Kingdom, CM3 8XA.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. Modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business, and is shown net of VAT.

The company recognises revenue from the following major sources:

- medical consultancy

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recover able.

1.3
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and was amortised on a systematic basis over its expected life.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

ANAESTHETIC RESOURCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

ANAESTHETIC RESOURCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
1
Accounting policies
(Continued)
- 4 -
1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
4
Intangible fixed assets
Goodwill
£
Cost
At 1 May 2024 and 30 April 2025
47,900
Amortisation and impairment
At 1 May 2024 and 30 April 2025
47,900
Carrying amount
At 30 April 2025
-
0
At 30 April 2024
-
0
ANAESTHETIC RESOURCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2025
- 5 -
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 May 2024 and 30 April 2025
8,551
Depreciation and impairment
At 1 May 2024
5,026
Depreciation charged in the year
1,175
At 30 April 2025
6,201
Carrying amount
At 30 April 2025
2,350
At 30 April 2024
3,525
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
14,594
14,769
7
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
-
0
492
Other creditors
8,678
4,618
8,678
5,110
2025-04-30 2024-05-01 false false false 15 May 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Dr H Ruschen Mrs M E Ruschen 06881034 2024-05-01 2025-04-30 06881034 2025-04-30 06881034 2024-04-30 06881034 core:OtherPropertyPlantEquipment 2025-04-30 06881034 core:OtherPropertyPlantEquipment 2024-04-30 06881034 core:ShareCapital 2025-04-30 06881034 core:ShareCapital 2024-04-30 06881034 core:RetainedEarningsAccumulatedLosses 2025-04-30 06881034 core:RetainedEarningsAccumulatedLosses 2024-04-30 06881034 bus:Director1 2024-05-01 2025-04-30 06881034 core:Goodwill 2024-05-01 2025-04-30 06881034 core:ComputerEquipment 2024-05-01 2025-04-30 06881034 2023-05-01 2024-04-30 06881034 core:NetGoodwill 2024-04-30 06881034 core:NetGoodwill 2025-04-30 06881034 core:NetGoodwill 2024-04-30 06881034 core:OtherPropertyPlantEquipment 2024-04-30 06881034 core:OtherPropertyPlantEquipment 2024-05-01 2025-04-30 06881034 core:CurrentFinancialInstruments 2025-04-30 06881034 core:CurrentFinancialInstruments 2024-04-30 06881034 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 06881034 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 06881034 bus:FRS102 2024-05-01 2025-04-30 06881034 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 06881034 bus:Director2 2024-05-01 2025-04-30 06881034 bus:FullAccounts 2024-05-01 2025-04-30 xbrli:pure xbrli:shares iso4217:GBP